Christophe Martin

1.1k total citations
14 papers, 869 citations indexed

About

Christophe Martin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Christophe Martin has authored 14 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Christophe Martin's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (3 papers). Christophe Martin is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (3 papers). Christophe Martin collaborates with scholars based in France, Switzerland and Spain. Christophe Martin's co-authors include Matti Aapro, Markus Borner, Amit M. Oza, Stephen Falk, James Carmichael, Torben Skovsgaard, David Radstone, Stéphane Munier, Tadeusz Popiela and J. Wanders and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Christophe Martin

13 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christophe Martin France	11	660	309	166	112	107	14	869
Yvonne Lassere United States	14	761 1.2×	320 1.0×	205 1.2×	146 1.3×	69 0.6×	20	887
C.G. Alexopoulos Greece	15	421 0.6×	219 0.7×	123 0.7×	148 1.3×	118 1.1×	34	789
Carlos A. Garay United States	9	643 1.0×	271 0.9×	196 1.2×	93 0.8×	220 2.1×	15	860
P. Harper United Kingdom	18	551 0.8×	278 0.9×	154 0.9×	210 1.9×	69 0.6×	43	1.1k
Frédérique Maindrault‐Gœbel France	8	757 1.1×	299 1.0×	147 0.9×	141 1.3×	167 1.6×	14	966
Véronique Guerin‐Meyer France	10	662 1.0×	309 1.0×	177 1.1×	117 1.0×	55 0.5×	32	820
John J. Gullo United States	10	1.0k 1.6×	361 1.2×	204 1.2×	192 1.7×	69 0.6×	18	1.3k
Olivier Capitain France	15	535 0.8×	269 0.9×	160 1.0×	115 1.0×	54 0.5×	59	826
Woo Kun Kim South Korea	13	376 0.6×	242 0.8×	107 0.6×	53 0.5×	78 0.7×	36	643
Karen Rittweger United States	14	967 1.5×	367 1.2×	280 1.7×	134 1.2×	173 1.6×	17	1.3k

Countries citing papers authored by Christophe Martin

Since Specialization

Citations

This map shows the geographic impact of Christophe Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Martin more than expected).

Fields of papers citing papers by Christophe Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Martin. The network helps show where Christophe Martin may publish in the future.

Co-authorship network of co-authors of Christophe Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Martin. A scholar is included among the top collaborators of Christophe Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Martin. Christophe Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Martin, Christophe, et al.. (2022). Length of stay and reason for admission in an adolescents inpatient unit. European Psychiatry. 65(S1). S445–S445.

Kellouche, Sabrina, Christophe Martin, Roger Rezzonico, et al.. (2007). Tissue engineering for full-thickness burns: A dermal substitute from bench to bedside. Biochemical and Biophysical Research Communications. 363(3). 472–478. 25 indexed citations

Mackay, Helen, Mark Hill, Chris Twelves, et al.. (2003). A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer. Annals of Oncology. 14(8). 1264–1269. 28 indexed citations

Carmichael, James, Tadeusz Popiela, David Radstone, et al.. (2002). Randomized Comparative Study of Tegafur/Uracil and Oral Leucovorin Versus Parenteral Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer. Journal of Clinical Oncology. 20(17). 3617–3627. 208 indexed citations

Borner, M., Patrick Schöffski, Ronald de Wit, et al.. (2002). Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin. European Journal of Cancer. 38(3). 349–358. 274 indexed citations

Aapro, Matti, et al.. (1998). Gemcitabine—a safety review. Anti-Cancer Drugs. 9(3). 191–202. 179 indexed citations

Abad, Albert, Matilde Navarro, Javier Sastre, et al.. (1997). A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).. PubMed. 11(9 Suppl 10). 53–7. 14 indexed citations

Cortés-Funes, H., Christophe Martin, Raymond P. Abratt, & Birthe Lund. (1997). Safety profile of gemcitabine, a novel anticancer agent, in non-small cell lung cancer. Anti-Cancer Drugs. 8(6). 582–587. 23 indexed citations

Dufour, P., H. Curé, Christophe Martin, et al.. (1996). 5-Fluorouracil versus 5-fluorouracil plus α-interferon as treatment of metastatic colorectal carcinoma. A randomized study. Annals of Oncology. 7(6). 575–579. 19 indexed citations

10.

Martin, Christophe, et al.. (1996). Gemcitabine: safety profile unaffected by starting dose.. PubMed. 16(1). 9–18. 8 indexed citations

11.

Martin, Christophe, Birthe Lund, Heather Anderson, & Nicholas Thatcher. (1996). Gemcitabine. Anti-Cancer Drugs. 7(3). 351–357. 13 indexed citations

12.

Martin, Christophe, Bendik Lund, Helén Anderson, & Nicholas Thatcher. (1996). Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule.. PubMed. 7(3). 351–7. 16 indexed citations

13.

Tonato, Maurizio, Anna Maria Mosconi, & Christophe Martin. (1995). Safety profile of gemcitabine. Anti-Cancer Drugs. 6(Supplement 6). 27–32. 59 indexed citations

14.

Fière, D, et al.. (1976). Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results.. PubMed. 25(9). 318–318. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact